<?xml version="1.0" encoding="UTF-8"?>
<p>Cross-reactive T cell responses were often observed between DENV and ZIKV, because of their homology at amino acid level. DENV specific memory CD8 + T cells could cross-react with Zika virus and protected mice from subsequent lethal ZIKV challenge (
 <xref rid="B191" ref-type="bibr">Wen et al., 2017a</xref>). Adoptive transfer of DENV CD8 + T cells to pregnant mice inhibited Zika virus replication in placenta and increased the survival of fetus (
 <xref rid="B147" ref-type="bibr">Regla-Nava et al., 2018</xref>). In DENV convalescent patients, memory CD4 + and CD8 + T cells could be activated by peptides derived from ZIKV capsid and NS3 proteins, and the activated CD8 + T cells could kill ZIKV infected cells 
 <italic>in vitro</italic> (
 <xref rid="B103" ref-type="bibr">Lim et al., 2018</xref>). Nevertheless, studies on the cross-reactive CD4 + T cells are few, evidence for ZIKV specific memory T cells cross-react with DENV antigens is still lacking.
</p>
